Syphilis Treatment Guidelines

Introduction to Syphilis Treatment

• The Centers for Disease Control and Prevention (CDC) recommends that benzathine penicillin G remains the only FDA-approved and guideline-recommended first-line treatment for all stages of syphilis 1, 2

Standard Treatment

• The CDC explicitly states that enhanced penicillin therapy (standard benzathine penicillin combined with high-dose oral amoxicillin and probenecid) did not improve clinical outcomes in early-stage syphilis and is not recommended 1

Alternative Treatments

• The American College of Physicians and other guideline societies recommend doxycycline 100 mg orally twice daily for 14 days for early syphilis, or 28 days for late latent syphilis, as a guideline-endorsed alternative for penicillin-allergic non-pregnant adults 2, 3
• Ceftriaxone 1 g IV/IM daily for 10 days is also a recommended alternative, with randomized trial data showing comparable efficacy to benzathine penicillin 2

Contraindications

• The CDC recommends that amoxicillin should not be used in pregnancy, as only parenteral penicillin G prevents maternal transmission and treats fetal infection; pregnant women with penicillin allergy must undergo desensitization 2, 3
• Amoxicillin should not be used for neurosyphilis, which requires IV aqueous crystalline penicillin G 18-24 million units daily for 10-14 days 1, 2

Monitoring Requirements

• If amoxicillin is used due to genuine penicillin unavailability, mandatory close monitoring includes quantitative nontreponemal tests (RPR or VDRL) at 3, 6, 12, and 24 months 2, 3
• Expected fourfold decline in titer within 6 months for primary/secondary syphilis, with the same nontreponemal test method used throughout follow-up 2, 3